Herbas VPB

Print
EN | LT
LT - Vėžio gydymas deriniu agento, kuris trikdo EGF signalinį kelią, ir oligonukleotido, kuris mažina klusterino lygį
EN - TREATMENT OF CANCER WITH A COMBINATION OF AN AGENT THAT PERTURBS THE EGF SIGNALING PATHWAY AND AN OLIGONUCLEOTIDE THAT REDUCES CLUSTERIN LEVELS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 48/00 (2006.01)
A61P 35/00 (2006.01)
A61K 39/395 (2006.01)
A61K 31/7088 (2006.01)
European patent
(11) Number of the document 1814595
(13) Kind of document T
(96) European patent application number 05810600.6
Date of filing the European patent application 2005-11-22
(97) Date of publication of the European application 2007-08-08
(45) Date of publication and mention of the grant of the patent 2014-01-08
(46) Date of publication of the claims translation 2014-07-25
PCT application
(86) Number PCT/CA2005/001775
Date 2005-11-22
PCT application publication
(87) Number WO 2006/056054
Date 2006-06-01
Priority applications
(30) Number Date Country code
522948 P 2004-11-23 US
522960 P 2004-11-24 US
Inventors
(72)
GLEAVE, Martin, CA
ZUPI, Gabriella, IT
Grantee
(73) THE UNIVERSITY OF BRITISH COLUMBIA, No 103 - 6190 Agronomy Road, Vancouver, British Columbia V6T 1Z3, CA
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Vėžio gydymas deriniu agento, kuris trikdo EGF signalinį kelią, ir oligonukleotido, kuris mažina klusterino lygį
  TREATMENT OF CANCER WITH A COMBINATION OF AN AGENT THAT PERTURBS THE EGF SIGNALING PATHWAY AND AN OLIGONUCLEOTIDE THAT REDUCES CLUSTERIN LEVELS
Last renewal fee
Payment date Validity (years) Amount
2014-10-22 10 800.00 LTL
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2015-11-22